SARS-CoV-2-correlated ASGR1 is a novel potential marker for the treatment and identification of multiple human cancers.
Year: 2022
Type: article
Abstract: OBJECTIVES: in various human cancers. METHODS: in various cancers were also investigated. RESULTS: expression are sensitive to 25 drugs, including ulixertinib. CONCLUSIONS: is a novel marker that can be used for treating and identifying multiple human cancers.
Source: PubMed
Author: Tao Huang
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W4315620798
